Week of September 15 - 21, 2019


Respiratory Gating

An overview of respiratory gating, which involves certain breathing techniques used during radiation therapy. The most common types of respiratory gating are discussed.

Fedratinib (Inrebic®)

Fedratinib (Inrebic®) is a type of targeted therapy called a kinase inhibitor, used in the treatment of Myelofibrosis.

Entrectinib (Rozlytrek™)

Entrectinib (Rozlytrek™) is a kinase inhibitor used in the treatment of non small cell lung cancer and other solid tumors with certain neurotrophic receptor kinase (NTRK) genes.

Darolutamide (Nubeqa®)

Darolutamide (Nubeqa®) is an androgen receptor inhibitor used in the treatment of patients with non-metastatic, castration-resistant prostate cancer.

Rituximab-pvvr (Ruxience™)

Rituximab-pvvr (Ruxience™) is a biosimilar monoclonal antibody used in the treatment of some types of leukemias and lymphomas. 

Selinexor (Xpovio™)

Selinexor (Xpovio™) is a nuclear export inhibitor used in the treatment of multiple myeloma.

Trastuzumab-anns (Kanjinti™)

Trastuzumab-anns (Kanjinti™) is a biosimilar monoclonal antibody used in the treatment of some types of breast and gastric cancer.

Bevacizumab-bvzr (Zirabev®)

Bevacizumab-bvzr (Zirabev®) is a biologic therapy that works by slowing down or stopping blood supply to cancer cells, thereby slowing their growth.

Filgrastim-aafi (Nivestym™)

Filgrastim-aafi (Nivestym™) is a colony stimulating factor biosimilar that is used to promote the production and function of blood cells. 

Filgrastim-sndz (Zarxio®)

Filgrastim-sndz (Zarxio®) is a colony stimulating factor biosimilar that is used to promote the production and function of blood cells. 

Pegfilgrastim-cbqv (Udenyca®)

Pegfilgrastim-cbqv (Udenyca®) is a type of colony stimulating factor, which is a group of medications that stimulate the production and function of blood cells, including white blood cells, red blood cells and platelets. 

Trastuzumab-qyyp (Trazimera™)

Trastuzumab-qyyp (Trazimera™) is a biosimilar monoclonal antibody used in the treatment of some types of breast and gastric cancer.

Tagraxofusp-erzs (Elzonris™)

Tagraxofusp-erzs (Elzonris™) is a chemotherapy used in the treatment of some types of blastic plasmacytoid dendritic cell neoplasm. 

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
X
Y
Z
#
 
A
B
C
E
F
G
H
K
L
M
N
O
P
R
S
T
U
V
 
 
Manténgase informado con las última información de OncoLink!   Suscribirse a los boletines electronico de OncoLink
Ver nuestros archivos de boletines